Clinical Trials List
2021-08-01 - 2024-11-01
Phase II
Recruiting4
Terminated1
ICD-10C33
Malignant neoplasm of trachea
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.0
Malignant neoplasm of trachea
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Chia-Chi Lin Division of Hematology & Oncology
- Chong-Jen Yu Division of General Internal Medicine
- 廖唯昱 Division of General Internal Medicine
- 吳尚俊 Division of General Internal Medicine
- 廖斌志 Division of Hematology & Oncology
- 陳冠宇 Division of General Internal Medicine
- 蔡子修 Division of General Internal Medicine
- 徐偉勛 Division of Hematology & Oncology
- CHAO-CHI HO CHAO-CHI HO Division of General Internal Medicine
- 楊景堯 Division of General Internal Medicine
- Jih-Hsiang Lee Division of Hematology & Oncology
- JIN-YUAN SHIH Division of General Internal Medicine
- 許嘉林 Division of General Internal Medicine
- YEN-TING LIN Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 陳正雄 Division of Thoracic Medicine
- 張竣期 Division of Thoracic Medicine
- 詹博強 Division of Thoracic Medicine
- 施穎銘 Division of Thoracic Medicine
- 林俊維 Division of Thoracic Medicine
- 林慶雄 Division of Thoracic Medicine
- 紀炳銓 Division of Thoracic Medicine
- 黃國揚 Division of Thoracic Medicine
- 葉金水 Division of Thoracic Medicine
- 蔡偉宏 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chih-Hung Chen Division of Hematology & Oncology
- 林定佑 Division of Hematology & Oncology
- 邱立忠 Division of Thoracic Medicine
- Cheng-Ta Yang Division of Hematology & Oncology
- Chih-Liang Wang Division of Hematology & Oncology
- 黃宗楨 Division of Hematology & Oncology
- Chien-Ying Liu Division of Hematology & Oncology
- 柯皓文 Division of Hematology & Oncology
- 枋岳甫 Division of Thoracic Medicine
- Chih-Hsi Kuo Division of Hematology & Oncology
- Shih-Hong Li Division of Hematology & Oncology
- Chih-Hung Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
240 participants
